Back The Wall Street Journal South Korea Regulator Says Samsung BioLogics Violated Accounting Rules
Search Sections 16 Jul
Close
Advertisement
South Korea Regulator Says Samsung BioLogics Violated Accounting RulesUpdated13 Jul 4:02am

South Korea Regulator Says Samsung BioLogics Violated Accounting Rules

The Wall Street Journal
Samsung BioLogics intentionally breached accounting rules, South Korean financial regulators said, triggering a suspension in aftermarket trading of the drugmaker’s shares.
Read full story
 Like Comment
Advertisement
Marketing

Comments

No comments yet...
On the top

Date settings

Today is Monday, July 16, 2018

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

The Wall Street Journal

Close